BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6191491)

  • 1. Diastereomers of 5-S-cysteinyldopa.
    Agrup G; Edholm LE; Rorsman H; Rosengren E
    Acta Derm Venereol; 1983; 63(1):59-61. PubMed ID: 6191491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidation of dopa in the skin of black and albino mice.
    Carstam R; Hansson C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1986; 66(5):369-74. PubMed ID: 2431571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-S-cysteinyldopa as a substrate for tyrosinase.
    Hansson C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1980; 60(5):399-402. PubMed ID: 6162310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid-chromatographic determination of 5-S-L-cysteinyl-L-dopa with electrochemical detection in urine prepurified with a phenylboronate affinity gel.
    Kågedal B; Pettersson A
    Clin Chem; 1983 Dec; 29(12):2031-4. PubMed ID: 6416708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-OH-dopa, product of and substrate for tyrosinase.
    Agrup G; Rorsman H; Rosengren E
    Acta Derm Venereol; 1982; 62(5):371-76. PubMed ID: 6183884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-bound dopa and 5-S-cysteinyldopa in non-melanogenic tissues.
    Ito S; Jimbow K; Kato T; Kiyota M; Fujita K
    Acta Derm Venereol; 1983; 63(6):463-7. PubMed ID: 6198833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-S-Cysteinyldopa and dopa in serum during treatment with 8-methoxypsoralen and UVA light.
    Hansson C; Rorsman H; Rosengren E; Tegner E
    Acta Derm Venereol; 1981; 61(3):251-5. PubMed ID: 6167110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of 5-S-cysteinyldopa by high performance liquid chromatography in biopsies from patients with dysplastic melanocytic nevi.
    Halldin MM; Cook WS; Kawashima T; Crutcher WA; Fukuyama K
    Cancer Res; 1987 Jan; 47(2):636-8. PubMed ID: 3098416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of cysteine conjugates from dihydroxyphenylalanine and its S-cysteinyl derivatives by peroxidase-catalyzed oxidation.
    Ito S; Fujita K
    Biochim Biophys Acta; 1981 Jan; 672(2):151-7. PubMed ID: 6784771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pronounced formation of 5-OH-dopa at enzymatic oxidation of DOPA in the presence of ascorbic acid.
    Hansson C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1981; 61(2):147-8. PubMed ID: 6165191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary 5-S-cysteinyldopa in Parkinsonism after DOPA and carbidopa.
    Stewart RM; Miller S; Gunder M
    Acta Derm Venereol; 1983; 63(2):97-101. PubMed ID: 6189350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-S-cysteinyldopa, dopa, and dopamine in the kidney and some other tissues.
    Agrup G; Hansson C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1980; 60(1):63-4. PubMed ID: 6153836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved solid-phase extraction and liquid chromatography with electrochemical detection of urinary catecholamines and 5-S-L-cysteinyl-L-dopa.
    Huang TH; Wall J; Kabra P
    J Chromatogr; 1988 Oct; 452():409-18. PubMed ID: 3149647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of cysteine on oxidation of tyrosine, dopa, and cysteinyldopas.
    Agrup G; Hansson C; Rorsman H; Rosengren E
    Arch Dermatol Res; 1982; 272(1-2):103-15. PubMed ID: 6819815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free and bound 5-S-cysteinyldopa and dopa in human malignant melanomas.
    Agrup G; Hansson C; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1978; 58(3):270-2. PubMed ID: 78645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of 5-S-glutathionyldopa.
    Carstam R; Edner C; Hansson C; Lindbladh C; Rorsman H; Rosengren E
    Acta Derm Venereol Suppl (Stockh); 1986; 126():1-12. PubMed ID: 3103358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular distribution of dopa and 5-S-cysteinyldopa in Harding-Passey melanoma.
    Agrup G; Falck B; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1977; 57(4):313-5. PubMed ID: 70922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The quantitative determination of 5-S-cysteinyldopa and dopa in normal serum and in serum from patients with malignant melanoma by means of high-pressure liquid chromatography.
    Hansson C; Edholm LE; Agrup G; Rorsman H; Rosengren AM; Rosengren E
    Clin Chim Acta; 1978 Sep; 88(3):419-27. PubMed ID: 699334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective toxicity of 5-S-cysteinyldopa, a melanin precursor, to tumor cells in vitro and in vivo.
    Fujita K; Ito S; Inoue S; Yamamoto Y; Takeuchi J; Shamoto M; Nagatsu T
    Cancer Res; 1980 Jul; 40(7):2543-6. PubMed ID: 6771000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new amino acid, 3-(2,5-SS-dicysteinyl-3,4-dihydroxyphenyl)alanine, from the tapetum lucidum of the gar (Lepisosteidae) and its enzymic synthesis.
    Ito S; Nicol JA
    Biochem J; 1977 Mar; 161(3):499-507. PubMed ID: 403909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.